Previsioni di mercato dei vaccini a base vegetale per il Nord America fino al 2028 – Impatto del COVID-19 e analisi regionale per tipo di vaccino (vaccini batterici, vaccini virali, vaccini antiparassitari e altri), fonte (pianta di tabacco, mais, patate e altri) e applicazione (Influenza, virus Zika, virus Ebola, malattie del pollame e altri)
Introduzione al mercato
Il mercato dei vaccini a base vegetale in Nord America è suddiviso in Stati Uniti, Canada e Messico. È probabile che il Nord America conquisti una quota significativa del mercato globale nel 2021. I fattori chiave che stanno guidando la crescita del mercato sono l’aumento del numero di lanci di prodotti insieme allo stimolo delle attività di ricerca e sviluppo. Tuttavia, durante il periodo di previsione è probabile che il mercato venga frenato da fattori quali le sfide associate all\'approvazione del prodotto e la contaminazione e i rischi ambientali legati alla produzione di vaccini a base vegetale.
< span>Il Nord America è una delle regioni più importanti per l\'adozione e la crescita di nuove tecnologie grazie alle lusinghiere politiche governative volte a stimolare l\'innovazione, alla presenza di un\'enorme base industriale e all\'elevato potere d\'acquisto dei consumatori, principalmente nei principali paesi come il Stati Uniti e Canada. Pertanto, qualsiasi impatto sulla crescita delle industrie influisce negativamente sulla crescita economica della regione. Gli Stati Uniti sono il paese più colpito al mondo a causa dell\'epidemia di COVID-19. Gli Stati Uniti sono un importante mercato per i vaccini a base vegetale poiché i principali attori del mercato si trovano negli Stati Uniti. La chiusura di fabbriche e attività commerciali negli Stati Uniti, in Canada e in Messico ha avuto un impatto negativo su vari settori nel 2020. D\'altro canto, la pandemia ha offerto opportunità di crescita vitali per gli operatori che operano nel mercato dei vaccini a base vegetale a causa del crescente numero di casi di COVID-19. 19 pazienti. Ad esempio, diverse aziende stanno portando avanti la ricerca e lo sviluppo per la creazione di vaccini contro il COVID-19 a base vegetale. Ad esempio, nel giugno 2021, iBio, un innovatore biotecnologico e un\'organizzazione di produzione a contratto di prodotti biologici, ha annunciato che gli studi preclinici su IBIO-202, il suo candidato vaccino a subunità che prende di mira la proteina nucleocapside (\"proteina N\") di SARS-CoV-2, ha dimostrato una risposta robusta, antigene-specifica e delle cellule T di memoria. Lo sviluppo di vaccini di origine vegetale alimenta la crescita del mercato.
Panoramica e dinamiche del mercato
Si prevede che il mercato dei vaccini a base vegetale nel Nord America crescerà da 498,66 milioni di dollari USA nel 2021 a 1.181,06 milioni di dollari entro il 2028; si stima che crescerà a un CAGR del 13,1% dal 2021 al 2028. I disturbi o le malattie infettive sono causati da microrganismi patogeni come batteri, virus, parassiti o funghi e possono essere trasmessi da una persona all\'altra direttamente o indirettamente . Queste malattie possono essere suddivise in tre categorie: malattie che causano alti livelli di mortalità, malattie che causano un grande carico di disabilità alle popolazioni e malattie che, a causa della loro diffusione rapida e inaspettata, possono avere gravi conseguenze. Molti dei principali fattori sanitari e delle cause di malattie infettive sfuggono al controllo diretto del settore sanitario. Tra gli altri settori coinvolti vi sono servizi igienico-sanitari e approvvigionamento idrico, ambiente e cambiamenti climatici, istruzione, agricoltura, commercio, turismo, trasporti, sviluppo industriale e edilizia abitativa.
Segmenti chiave del mercato
Nord Il mercato americano dei vaccini a base vegetale è segmentato in tipo di vaccino, fonte, applicazione e paese. In base al tipo di vaccino, il mercato dei vaccini a base vegetale del Nord America è segmentato in vaccini batterici, vaccini virali, vaccini antiparassitari, particelle simili a virus di origine vegetale e altri. Il segmento dei vaccini batterici deteneva la quota maggiore del mercato nel 2021. In base alla fonte, il mercato dei vaccini a base vegetale del Nord America è segmentato in pianta del tabacco, mais, patate e altri. Il segmento delle piante di tabacco ha detenuto la quota maggiore del mercato nel 2021. In base all’applicazione, il mercato dei vaccini a base vegetale del Nord America è segmentato in influenza, virus Zika, virus Ebola, malattie del pollame, COVID-19 e altri. Il segmento dell’influenza deteneva la quota maggiore del mercato nel 2021. In base al paese, il mercato dei vaccini a base vegetale del Nord America è segmentato negli Stati Uniti, Canada e Messico. Gli Stati Uniti hanno detenuto la quota di mercato maggiore nel 2021.
Principali fonti e società quotate
Alcune delle principali fonti primarie e secondarie a cui si fa riferimento per la preparazione di questo rapporto sul mercato dei vaccini a base vegetale in Nord America sono siti Web aziendali, relazioni annuali, relazioni finanziarie, documenti governativi nazionali e database statistici, tra gli altri . Le principali società elencate nel rapporto sono British American Tobacco plc; Creative Biolabs, Inc.; Fraunhofer; iBio, Inc.; Foglia Espressione Systems Ltd.; LenioBio; Lumen Bioscience, Inc.; Medicago, Inc.; e ZYUS Life Sciences Inc.
Motivi per acquistare il rapporto
- Comprendere il panorama del mercato dei vaccini a base vegetale in Nord America e identificare i segmenti di mercato che sono molto probabilmente garantirà un forte ritorno.
- Stai al passo con la corsa comprendendo il panorama competitivo in continua evoluzione per il mercato dei vaccini a base vegetale in Nord America.
- Pianificare in modo efficiente operazioni di fusione e acquisizione e accordi di partnership nel mercato dei vaccini a base vegetale in Nord America identificando i segmenti di mercato con le vendite probabili più promettenti.
- Aiuta prendere decisioni aziendali consapevoli partendo da un\'analisi percettiva e completa delle prestazioni del mercato dei vari segmenti del mercato dei vaccini a base vegetale del Nord America.
- Ottenere previsioni sulle entrate del mercato per i vari segmenti a partire dal 2021 -2028 nella regione del Nord America.
Nord America Mercato dei vaccini di origine vegetale Segmentazione
Mercato dei vaccini a base vegetale in Nord America - Per tipo di vaccino
- Vaccini batterici
- Vaccini virali
- Vaccini antiparassitari
- Particelle simili a virus di origine vegetale
- Altri
Mercato dei vaccini a base vegetale in Nord America - Per Fonte
- Pianta di tabacco
- Mais
- Patata
- Altro
Nord America A base vegetale Mercato dei vaccini: per applicazione
- Influenza
- Virus Zika
- Virus Ebola
- COVID-19
- Malattia del pollame
- Altri
Mercato dei vaccini a base vegetale in Nord America: per paese
- Stati Uniti
- Canada
- Messico
Mercato dei vaccini a base vegetale in Nord America - Profili aziendali
- British American Tobacco plc
- Creative Biolabs, Inc.
- Fraunhofer
- iBio, Inc.
- Leaf Expression Systems Ltd.
- < span>LenioBio
- Lumen Bioscience, Inc.
- Medicago, Inc.
- ZYUS Life Sciences Inc.
TABLE OF CONTENTS
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 North America Plant-based Vaccines Market – By Vaccine Type
1.3.2 North America Plant-based Vaccines Market – By Source
1.3.3 North America Plant-based Vaccines Market – By Application
1.3.4 North America Plant-based Vaccines Market – By Country
2. North America Plant-based Vaccines Market – Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. North America Plant-based Vaccines Market– Market Landscape
4.1 Overview
4.2 North America PEST Analysis
4.3 Experts Opinion
5. North America Plant-based Vaccines Market – Key Market Dynamics
5.1 Market Drivers
5.1.1 Plant-Based Vaccines Witnessing Rising Number of Research & Development (R&D) Activities
5.1.2 Rising Instances of Infectious Diseases
5.2 Market Restraints
5.2.1 High Risk of Contamination Including Environmental Risks for Manufacturing Plant-Based Vaccines
5.3 Market Opportunities
5.3.1 Enhancements in Production of Plant-Based Vaccines
5.4 Future Trends
5.4.1 Rise in Product Approvals and Increase in Prevalence of Infectious Diseases
5.5 Impact Analysis
6. Plant-based Vaccines Market– North America Analysis
6.1 North America Plant-based Vaccines Market Revenue Forecast and Analysis
7. North America Plant-Based Vaccines Market Analysis – By Vaccine Type
7.1 Overview
7.2 North America Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)
7.3 Bacterial Vaccines
7.3.1 Overview
7.3.2 Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.4 Viral Vaccines
7.4.1 Overview
7.4.2 Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.5 Parasite Vaccines
7.5.1 Overview
7.5.2 Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.6 Plant-derived Virus-like Particles (VLPs)
7.6.1 Overview
7.6.2 Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
7.7 Others
7.7.1 Overview
7.7.2 Others: Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
8. North America Plant-based Vaccines Market Analysis – By Source
8.1 Overview
8.2 North America Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)
8.3 Tobacco Plant
8.3.1 Overview
8.3.2 Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.4 Maize
8.4.1 Overview
8.4.2 Maize: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.5 Potato
8.5.1 Overview
8.5.2 Potato: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
8.6 Others
8.6.1 Overview
8.6.2 Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9. North America Plant-based Vaccines Market Analysis– by Application
9.1 Overview
9.2 North America Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)
9.3 Influenza
9.3.1 Overview
9.3.2 Influenza: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.4 Zika Virus
9.4.1 Overview
9.4.2 Zika Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.5 Ebola Virus
9.5.1 Overview
9.5.2 Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.6 Poultry Disease
9.6.1 Overview
9.6.2 Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.7 Covid-19
9.7.1 Overview
9.7.2 Covid-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
9.8 Others
9.8.1 Overview
9.8.2 Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
10. North America Plant-based Vaccines Market – Country Analysis
10.1 North America: Plant based vaccines Market
10.1.1 Overview
10.1.2 North America: Plant-Based Vaccines Market, by Country, 2021 & 2028 (%)
10.1.2.1 US: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.1 US: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.2 US Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.3 US Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.2.1.4 US Plant-Based Vaccines Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.2.2 Canada: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.1 Canada: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.2 Canada Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.2.2.3 Canada Plant-Based Vaccines Market, by Source– Revenue and Forecast to 2028 (USD Million)
10.1.2.2.4 Canada Plant-Based Vaccines Market, by Application– Revenue and Forecast to 2028 (USD Million)
10.1.2.3 Mexico: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.1 Mexico: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.2 Mexico Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.3 Mexico Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
10.1.2.3.4 Mexico Plant-Based Vaccines Market, by Application– Revenue and Forecast to 2028 (USD Million)
11. Impact Of COVID-19 Pandemic On North America Plant-based Vaccines Market
11.1 North America: Impact Assessment of COVID-19 Pandemic
12. Plant-based Vaccines Market –Industry Landscape
12.1 Overview
12.2 Growth Strategies in the Plant-based Vaccines Market, 2019-2021
12.3 Organic Developments
12.3.1 Overview
12.4 Inorganic Developments
12.4.1 Overview
13. Company Profiles
13.1 MEDICAGO, INC.
13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments
13.2 British American Tobacco p.l.c.
13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments
13.3 CREATIVE BIOLABS, INC.
13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments
13.4 iBio, Inc.
13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments
13.5 LENIOBIO
13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments
13.6 Lumen Bioscience, Inc.
13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments
13.7 LEAF EXPRESSION SYSTEMS LTD.
13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments
13.8 ZYUS LIFE SCIENCES INC.
13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments
13.9 FRAUNHOFER CMB
13.9.1 Key Facts
13.9.2 Business Description
13.9.3 Products and Services
13.9.4 Financial Overview
13.9.5 SWOT Analysis
13.9.6 Key Developments
14. Appendix
14.1 About The Insight Partners
14.2 Glossary of Terms
LIST OF TABLES
Table 1. US Plant-Based Vaccines Market, by Vaccine Type – Revenue and Forecast to 2028 (USD Million)
Table 2. US Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 3. US Plant-Based Vaccines Devices Market, by Application– Revenue and Forecast to 2028 (USD Million)
Table 4. Canada Plant-Based Vaccines Market, by Vaccine Type -Revenue and Forecast to 2028 (USD Million)
Table 5. Canada Plant-Based Vaccines Market, by Source - Revenue and Forecast to 2028 (USD Million)
Table 6. Canada Plant-Based Vaccines Devices Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 7. Mexico Plant-Based Vaccines Market, by Vaccine Type -Revenue and Forecast to 2028 (USD Million)
Table 8. Mexico Plant-Based Vaccines Market, by Source – Revenue and Forecast to 2028 (USD Million)
Table 9. Mexico Plant-Based Vaccines Market, by Application – Revenue and Forecast to 2028 (USD Million)
Table 10. Recent organic developments in the Plant-based Vaccines Market
Table 11. Glossary of Terms, North America Plant-based Vaccines devices market
LIST OF FIGURES
Figure 1. North America Plant-based Vaccines Market Segmentation
Figure 2. North America Plant-based Vaccines Market Segmentation, By Country
Figure 3. North America Plant-based Vaccines Market Overview
Figure 4. Bacterial Vaccines Held the Largest Share of the Vaccine Type Segment in North America Plant-based Vaccines Market
Figure 5. US to Show Significant Growth during Forecast Period
Figure 7. North America PEST Analysis
Figure 8. North America Plant-Based Vaccines Market Impact Analysis of Driver and Restraints
Figure 9. North America Plant-based Vaccines Market– Revenue Forecast and Analysis – 2019- 2028
Figure 10. North America Plant-based Vaccines Market Revenue Share, by Vaccine Type (2021 and 2028)
Figure 11. North America Bacterial Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 12. North America Viral Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 13. North America Parasite Vaccines: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 14. North America Plant-derived Virus-like particles (VLPs): Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 15. North America Others: Plant-based Vaccines Market – Revenue and Forecast to 2028 (US$ Million)
Figure 16. North America Plant-based Vaccines Market Revenue Share, by Source (2021 and 2028)
Figure 17. North America Tobacco Plant: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 18. North America Maize: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 19. North America Potato: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 20. North America Others: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 21. North America Plant-based Vaccines Market Revenue Share, by Application (2021 and 2028)
Figure 22. North America Influenza: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 23. North America Zika Virus: Plant-based Vaccines Market - Revenue and Forecasts to 2028 (US$ Mn)
Figure 24. North America Ebola Virus: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 25. North America Poultry Disease: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 26. North America Covid-19: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 27. North America Others: Plant-based Vaccines Market - Revenue and Forecast to 2028 (US$ Mn)
Figure 28. North America: Plant-Based Vaccines Market, by Key Country – Revenue (2021) (USD Million)
Figure 29. North America: Plant-Based Vaccines Market, by Country, 2021 & 2028 (%)
Figure 30. US: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 31. Canada: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 32. Mexico: Plant-Based Vaccines Market – Revenue and Forecast to 2028 (USD Million)
Figure 33. Impact of COVID-19 Pandemic in North American Country Markets
Figure 34. Growth Strategies in the Plant-based Vaccines Market, 2019-2021- British American Tobacco p.l.c.
- Creative Biolabs, Inc.
- Fraunhofer
- iBio, Inc.
- Leaf Expression Systems Ltd.
- LenioBio
- Lumen Bioscience, Inc.
- Medicago, Inc.
- ZYUS Life Sciences Inc.
- Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the North America plant-based vaccines market
- Highlights key business priorities in order to assist companies to realign their business strategies
- The key findings and recommendations highlight crucial progressive industry trends in the North America plant-based vaccines market, thereby allowing players across the value chain to develop effective long-term strategies
- Develop/modify business expansion plans by using substantial growth offering developed and emerging markets
- Scrutinize in-depth North America market trends and outlook coupled with the factors driving the plant-based vaccines market, as well as those hindering it
- Enhance the decision-making process by understanding the strategies that underpin commercial interest with respect to client products, segmentation, pricing and distribution